Description
Researchers studying the GHRH pathway need a stable, well-documented compound with a predictable half-life. Short-acting native GHRH degrades in minutes, which makes sustained pituitary studies difficult without frequent dosing schedules.
How it helps
CJC-1295 with DAC is a modified GHRH analogue where the DAC (Drug Affinity Complex) portion binds to serum albumin after injection. This binding protects the peptide from enzymatic breakdown and extends its half-life to roughly 6-8 days, supporting twice-weekly research protocols instead of daily dosing.
Each vial ships lyophilized from Canada and is verified at 99% or higher purity by HPLC. A Certificate of Analysis is available on request for every batch, giving researchers a documented reference for their work.
Features
- Active compound: GHRH Analogue + DAC (Modified GHRH(1-29) + DAC)
- Amount per vial: 2mg (2000 mcg)
- Form: Lyophilized white powder
- Purity: ≥99% (HPLC verified)
- Half-life: approximately 6-8 days
- Storage unreconstituted: -20°C long-term, 2-8°C short-term
- Storage reconstituted: refrigerated 2-8°C, use within 28-60 days
- Shelf life: 24 months unreconstituted when stored properly
- Shipping: discreet plain packaging, ships from Canada
- COA available on request for every batch
Quick answers
How should this vial be reconstituted?
Add 2mL of sterile bacteriostatic water (0.9% benzyl alcohol) slowly along the vial wall, then gently swirl until fully dissolved. This yields a concentration of 1000 mcg per mL.
How long does the reconstituted peptide last?
Once reconstituted, store the vial refrigerated at 2-8°C and use within 28-60 days depending on specific research requirements.
Is this product approved for human use?
No. This item is sold for research and laboratory purposes only and is not approved by Health Canada for human or veterinary use.
